Progress in polymeric nano-medicines for theranostic cancer treatment

Imran Ali*, Mosa Alsehli, Luciana Scotti, Marcus Tullius Scotti, Shang Ting Tsai, Ruei Siang Yu, Ming Fa Hsieh, Jung Chih Chen

*此作品的通信作者

研究成果: Article同行評審

101 引文 斯高帕斯(Scopus)

摘要

Cancer is a life-threatening disease killing millions of people globally. Among various medical treatments, nano-medicines are gaining importance continuously. Many nanocarriers have been developed for treatment, but polymerically-based ones are acquiring importance due to their targeting capabilities, biodegradability, biocompatibility, capacity for drug loading and long blood circulation time. The present article describes progress in polymeric nano-medicines for theranostic cancer treatment, which includes cancer diagnosis and treatment in a single dosage form. The article covers the applications of natural and synthetic polymers in cancer diagnosis and treatment. Efforts were also made to discuss the merits and demerits of such polymers; the status of approved nano-medicines; and future perspectives.
原文English
文章編號598
期刊Polymers
12
發行號3
DOIs
出版狀態Published - 6 3月 2020

指紋

深入研究「Progress in polymeric nano-medicines for theranostic cancer treatment」主題。共同形成了獨特的指紋。

引用此